Cosmecca Korea Expects 12% Rise in Q3 Operating Profit; Target Price ₩140,000–Sangsangin
Predicted impact: Medium
Forecast 12% rise in Q3 operating profit; a modest, expected change.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.